Genomtec S.A.
GMT.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 4 | PLN 6 | PLN 5 | PLN 0 |
| % Growth | -33.3% | 20% | – | – |
| Cost of Goods Sold | PLN 5,734 | PLN 3,071 | PLN 596 | -PLN 480 |
| Gross Profit | -PLN 5,730 | -PLN 3,065 | -PLN 1,092 | PLN 480 |
| % Margin | -143,250% | -51,083.3% | -21,840% | – |
| R&D Expenses | PLN 1,566 | PLN 1,097 | PLN 1,097 | PLN 2,398 |
| G&A Expenses | PLN 1,661 | PLN 0 | PLN 2,356 | -PLN 111 |
| SG&A Expenses | PLN 1,661 | PLN 1,214 | PLN 2,356 | -PLN 111 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 6,444 | -PLN 2,084 | -PLN 1,448 | PLN 81 |
| Operating Expenses | -PLN 3,217 | PLN 227 | PLN 2,005 | PLN 2,368 |
| Operating Income | -PLN 2,513 | -PLN 4,273 | -PLN 3,097 | -PLN 1,888 |
| % Margin | -62,825% | -71,216.7% | -61,940% | – |
| Other Income/Exp. Net | -PLN 53 | PLN 877 | -PLN 61 | -PLN 54 |
| Pre-Tax Income | -PLN 2,566 | -PLN 3,396 | -PLN 3,158 | -PLN 1,942 |
| Tax Expense | PLN 6 | PLN 46 | PLN 47 | -PLN 60 |
| Net Income | -PLN 2,572 | -PLN 3,350 | -PLN 3,205 | -PLN 1,882 |
| % Margin | -64,300% | -55,833.3% | -64,100% | – |
| EPS | -0.17 | -0.23 | -0.22 | -0.14 |
| % Growth | 26.1% | -4.5% | -57.1% | – |
| EPS Diluted | -0.17 | -0.23 | -0.22 | -0.14 |
| Weighted Avg Shares Out | 15,065 | 14,928 | 14,867 | 13,325 |
| Weighted Avg Shares Out Dil | 15,065 | 14,928 | 15,180 | 13,325 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 10 | PLN 54 | PLN 10 | PLN 10 |
| Interest Expense | PLN 41 | PLN 143 | PLN 47 | PLN 51 |
| Depreciation & Amortization | PLN 674 | PLN 855 | PLN 596 | PLN 605 |
| EBITDA | -PLN 1,851 | -PLN 2,437 | -PLN 2,515 | -PLN 1,287 |
| % Margin | -46,275% | -40,616.7% | -50,300% | – |